Effective January 30, 2013, AtriCure, Inc. (the "Company") and Silicon Valley Bank (the "Bank") entered into a Joinder and Fifth Loan Modification Agreement (the "Loan Modification Agreement") and an Export-Import Bank Joinder and Third Loan Modification Agreement (the "Ex-Im Agreement" and, collectively with the Loan Modification Agreement, the "Modification Agreements") which set forth certain amendments to the Company's credit facility with the Bank.

The Modification Agreements add the Company's wholly-owned subsidiary, AtriCure, LLC, as a borrower, and the Loan Modification Agreement modifies the Company's timing for submitting a forecast to the Bank and decreases the EBITDA amount the Company must achieve to meet the minimum EBITDA covenant.

The foregoing description of the Loan Modification Agreements is qualified in its entirety by the full text of the Loan Modification Agreement and the Ex-Im Agreement as attached to and filed with this Form 8-K as Exhibits 10.1 and 10.2, respectively.

The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

(d) Exhibits.

No.     Description

10.1    Joinder and Fifth Loan Modification Agreement between Silicon Valley Bank
        and AtriCure, Inc. dated January 30, 2013

10.2    Export-Import Bank Joinder and Third Loan Modification Agreement between
        Silicon Valley Bank and AtriCure, Inc. dated January 30, 2013